Why the study?
Does permanent pacemaker implantation affect mid- and long-term outcomes in patients undergoing TAVR or SAVR?
Does permanent pacemaker implantation affect mid- and long-term outcomes in patients undergoing TAVR or SAVR?
The clinical impact of permanent pacemaker implantation following TAVR or SAVR remains an unresolved issue requiring further clarity.
Despite advances in technologies and clinical experience, conduction disorders, after TAVR or SAVR, represent the weak point of these procedures, requiring permanent pacemaker implantation (PPI) till 37.7% of patients in TAVR recipients. The role of PPI in TAVR and SAVR remains controversial in mid- and long-term outcomes. Indeed, many studies have been published with contradictory results, leaving doubts rather than certainties.
No takes yet. Share an insight, caveat, or question.
Totaro et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: